1 Powell DW.Myofibroblasts:paracrine cells important in health and disease[J].Trans Am Clin Climatol Assoc, 2000;111:271-92
2 Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J.Biochemical assessment of myocardial fibrosis in hypertensive heart disease[J].Hypertension, 2001;38(5):1222-6
3 梁茜, 李榕生, 林爱珍.充血性心力衰竭患者血清Ⅲ 型前胶原氨基端肽检测的临床价值[J].中国医师杂志, 2002;4(6):641-2
4 申源生, 侯文振, 马伟东, 吕汉文.抗纤维化治疗对慢性心力衰竭患者血清纤维化指标的影响[J].心脏杂志,2002;14 (4):316-7
5 Lindsay MM, Maxwell P, Dunn FG.TIMP-1:a marker of left ventricular diastolic dysfunction and fibrosis in hypertension[J]. Hypertension, 2002;40(2):136-41
6 Brilla CG, Funck RC, Rupp H.Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease [J].Circulation, 2000;102(12):1388-93
7 Zhu YC, Zhu YZ, Gohlke P, Stauss HM, Unger T.Effects of angiotensin-conventing enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy[J].Am J Cardiol, 1997;80(3A):110A-7
8 Yang XP, Liu YH, Mehta D, Cavasin MA, Shesely E, Xu J, et al.Diminished cardioprotective response to inhibition of angiotensin-conventing enzyme and angiotensin II type1 receptor in (B2)kinin receptor gene knockout mice[J].Circ Res, 2001;88 (10):1072-9
9 Der Sarkissian S, Marchand EL, Duguay D, Hamet P, De Blois D.Reversal of interstitial fibroblast hyperplasia Via apoptosis in hypertensive rat heart with valsartan or enalapril[J].Cardiovasc Res, 2003;57(3):775-83
10 Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL.Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients[J].Circulation, 2002;105 (21):2512-7
11 Lim DS, Lutucuta S, Bachireddy P, Youker K, Evans A, EntmanM, et al.Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy[J].Circulation, 2001;103(6):789-91
12 Kim S, Yoshiyama M, Izumi Y, Kawano H, Kimoto M, Zhan Y, et al.Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure[J].Circulation, 2001;103 (1):148-54
13 Kurisu S, Ozono R, Oshima T, Kambe M, Ishida T, Sugino H, et al.Cardiac angiotensin II type 2 receptor activates kinin NO system and inhibits fibrosis[J].Hypertension, 2003;41 (1):99-107
14 Zannad F, Alla F, Dousset B, Perez A, Pitt B.Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure:insights from the randomized aldactone evaluation study (RALES)[J].Circulation, 2000;102(22):2700-6
15 Bertram P, Faiez Z, Willem J, Remme, Robert C, Alain C, et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J].N Engl J Med, 1999;314 (2):709-17
16 Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, et al.Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart faliure [J].J Am Coll Cardiol, 2000;36(3):838-44
17 Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, et al.Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure[J].J Am Coll Cardiol, 2001;37(5): 1228-33
18 Hayashi M, Tsutamoto T, Wada A, Tsutsui T, Ishii C, Ohno K, et al.Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction[J].Circulation, 2003;107(20):2559-65
19 Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, et al.The EPHESUS trial:eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction[J].Cardiovasc Drugs Ther, 2001;15 (1):79-87
20 Buchhorn R, Hulpke-Wette M, Ruschewski W, Ross RD, Fielitz J, Pregla R, et al.Effects of therapeutic beta blockade on myocardial function and cardiac remodelling in congenital cardiac disease[J].Cardiol Young, 2003;13(1):36-43
21 Pacca SR, De Azevedo AP, De Oliveira CF, De Luca IM, De Nucci G, Antunes E.Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis[J].J Cardiovasc Pharmacol, 2002;39(2):201-7
22 Grimm D, Huber M, Jabusch HC, Shakibaei M, Fredersdorf S, PaulM, et al.Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure overload: effects of beta-receptor blockade[J].JMol Cell Cardiol, 2001; 33(3):487-501
23 Lotze U, Heinke S, Fritzenwanger M, Krack A, Muller S, Figulla HR.Carvedilol inhibits platelet-derived growth factorinduced signal transduction in human cardiac fibroblasts[J].J Cardiovasc Pharmacol, 2002;39(4):576-89
24 Sandmann S, Claas R, Cleutjens JP, Daemen MJ, Unger T. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats[J].J Ardiovasc Pharmacol, 2001;37(1):64-77
25 Nishikawa N, Masuyama T, Yamamoto K, Sakata Y, Mano T, Miwa T, et al.Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats [J].J Am Coll Cardiol, 2001;38(5):1539-45
26 Hayashidani S, Tsutsui H, Shiomi T, Suematsu N, Kinugawa S, de T, et al.Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction[J]. Circulation, 2002;105(7):868-73
27 Bauersachs J, Galuppo P, Fraccarollo D, Christ M, Ertl G. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction[J]. Circulation, 2001;104(9):982-5
28 Patel R, Nagueh SF, Tsybouleva N, Abdellatif M, Lutucuta S, Kopelen HA, et al.Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy [J].Circulation, 2001;104(3):317-24
29 Lindsey ML, Gannon J, Aikawa M, Schoen FJ, Rabkin E, Lopresti-Morrow L, et al.Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction[J].Circulation, 2002; 105(6):753-8
30 Chancey AL, Brower GL, Peterson JT, Janicki JS.Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload[J].Circulation, 2002;105(16):1983-8
31 Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin EL.Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling[J].Hypertension, 2003;42(1):49-55
32 Mulder P, Boujedaini H, Richard V, Derumeaux G, Henry JP, Renet S, et al.Selective endothelin-A versus combined endothelin-a endothelin-b receptor blockade in rat chronic heart failure[J].Circulation, 2000;103(5):491-3
33 Nwogu JI, Geenen D, BeanM, Brenner MC, Huang X, Buttrick PM.Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction [J].Circulation, 2001;104(18):2216-21
34 唐忠志, 郑智, 唐瑛, 任大宏, 唐胜利.丹参对自发性高血压大鼠心肌纤维化的逆转作用及其机制研究[J].华中科技大学学报(医学版), 2002;313(3):292-4
35 陈静, 许喜泳, 刘淑华.银杏叶片对冠心病心绞痛患者血浆内皮素和一氧化氮含量的影响[J].数理医药学杂志,2002;15(6):517-8
36 宋德明, 苏海, 吴美华, 黄学明.川芎嗪、丹参对心肌成纤维细胞胶原合成和细胞增殖的影响[J].中国中西医结合杂志, 1998;18(7):423-5
37 丁志山, 高承贤, 吉瑞瑞, 沃兴德.血府逐瘀汤对心肌成纤维细胞增殖和胶原合成影响[J].中药材, 2002;25(7):481-3 |
